Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.41 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.76.
Market Cap
8.41T
Revenue
4.59T
Profits
201.46B
PE Ratio
41.76
Profit Margin
4.39%
Dividend Yield
0.43%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | 1.57% | 4,502,609 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 558.86B | -0.26% | 7,567,647 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 394.12B | -1.83% | 4,915,556 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 369.22B | 1.78% | 7,025,919 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 295.19B | -1.05% | 12,323,897 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 285.48B | -2.37% | 2,040,122 | 60.44B |
| 7 | NVS | Novartis AG | 269.49B | -1.84% | 2,591,962 | 56.58B |
| 8 | AMGN | Amgen Inc. | 186.59B | -1.10% | 2,488,194 | 37.22B |
| 9 | NVO | Novo Nordisk A/S | 186.16B | -4.52% | 20,690,142 | 50.57B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 174.52B | -0.67% | 1,939,461 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 159.05B | -0.82% | 9,801,673 | 29.74B |
| 12 | ABT | Abbott Laboratories | 157.63B | -0.63% | 13,308,540 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 148.26B | -0.82% | 2,180,420 | 10.58B |
| 14 | PFE | Pfizer Inc. | 146.02B | -1.61% | 42,116,928 | 63.32B |
| 15 | DHR | Danaher Corporation | 129.90B | -0.42% | 3,148,634 | 24.78B |
| 16 | CVS | CVS Health Corporation | 123.87B | 1.20% | 6,082,039 | 405.62B |
| 17 | SYK | Stryker Corporation | 115.59B | -1.35% | 1,677,041 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 113.48B | -2.97% | 12,344,065 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.43B | -0.87% | 1,149,269 | 12.22B |
| 20 | SNY | Sanofi | 106.26B | -2.53% | 1,879,268 | 54.60B |
| 21 | MDT | Medtronic plc | 103.60B | -1.20% | 10,254,394 | 36.36B |
| 22 | GSK | GSK plc | 101.89B | -1.71% | 4,836,306 | 43.29B |
| 23 | MCK | McKesson Corporation | 92.15B | -1.16% | 794,811 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 90.81B | 0.63% | 1,785,486 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 80.16B | -2.90% | 1,610,906 | 76.39B |
| 26 | CI | The Cigna Group | 76.61B | 0.04% | 1,512,296 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.39B | 0.31% | 15,379,680 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.20B | -3.79% | 1,259,201 | 14.92B |
| 29 | ARGX | argenx SE | 54.81B | -1.00% | 484,365 | 4.74B |
| 30 | COR | Cencora, Inc. | 53.33B | -0.35% | 893,888 | 328.68B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 49.83B | 0.90% | 3,934,296 | 28.34B |
| 32 | EW | Edwards Lifesciences Corporation | 49.43B | -0.13% | 4,374,139 | 6.30B |
| 33 | CAH | Cardinal Health, Inc. | 47.89B | -0.60% | 1,534,724 | 250.74B |
| 34 | MDLN | Medline Inc. | 44.40B | 0.57% | 9,041,135 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.27B | -0.18% | 370,538 | 4.45B |
| 36 | HUM | Humana Inc. | 42.74B | 1.69% | 1,117,724 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 41.33B | -0.77% | 1,925,949 | 22.23B |
| 38 | HLN | Haleon plc | 39.13B | -2.52% | 11,749,093 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.01B | -3.59% | 1,651,371 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 38.73B | -2.72% | 5,750,541 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 37.48B | -2.03% | 1,754,656 | 7.23B |
| 42 | WAT | Waters Corporation | 35.67B | -0.55% | 789,893 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.04B | -0.78% | 5,432,075 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.59B | -1.05% | 1,340,522 | 10.63B |
| 45 | CNC | Centene Corporation | 32.11B | 4.33% | 7,024,466 | 178.33B |
| 46 | RPRX | Royalty Pharma plc | 31.59B | -1.81% | 3,714,639 | 2.44B |
| 47 | RVMD | Revolution Medicines, Inc. | 31.57B | -0.50% | 2,734,779 | - |
| 48 | IQV | IQVIA Holdings Inc. | 30.66B | 0.13% | 1,203,603 | 16.63B |
| 49 | NTRA | Natera, Inc. | 30.57B | -0.85% | 1,115,090 | 2.50B |
| 50 | ONC | BeOne Medicines AG | 30.11B | 0.26% | 285,134 | 5.70B |
| 51 | DXCM | DexCom, Inc. | 29.57B | 5.16% | 7,571,234 | 4.82B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.42B | - | 4,635,596 | 20.98B |
| 53 | BIIB | Biogen Inc. | 28.44B | -1.39% | 1,157,705 | 9.94B |
| 54 | RMD | ResMed Inc. | 27.89B | -1.48% | 1,033,883 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 27.17B | -3.11% | 2,025,300 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 24.69B | -1.11% | 933,593 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 23.91B | -2.64% | 1,240,823 | 4.39B |
| 58 | UTHR | United Therapeutics Corporation | 23.12B | -0.94% | 448,559 | 3.17B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.01B | -1.34% | 183,267 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.59B | 1.67% | 594,642 | 3.22B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.83B | -1.54% | 821,691 | 11.28B |
| 62 | BNTX | BioNTech SE | 21.62B | -2.93% | 1,121,279 | 3.23B |
| 63 | LH | Labcorp Holdings Inc. | 21.48B | -1.18% | 507,007 | 14.14B |
| 64 | STE | STERIS plc | 20.50B | -0.80% | 721,515 | 5.94B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.49B | -0.31% | 6,072,626 | 8.26M |
| 66 | INSM | Insmed Incorporated | 20.41B | -0.05% | 5,010,324 | 819.56M |
| 67 | INCY | Incyte Corporation | 20.11B | -1.70% | 2,975,172 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.89B | 0.34% | 3,994,249 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.55B | 0.31% | 9,346,577 | 14.56B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.88B | -0.07% | 1,645,512 | 8.41B |
| 71 | GH | Guardant Health, Inc. | 16.56B | -0.57% | 2,212,806 | 1.08B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.40B | -0.46% | 802,001 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.27B | -1.39% | 1,435,020 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.56B | -2.74% | 1,208,493 | 4.44B |
| 75 | THC | Tenet Healthcare Corporation | 14.04B | 0.59% | 1,582,848 | 21.46B |
| 76 | SOLV | Solventum Corporation | 13.64B | -2.78% | 2,048,281 | 8.26B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.20B | -0.35% | 1,737,569 | 579.96M |
| 78 | MEDP | Medpace Holdings, Inc. | 13.08B | 0.80% | 186,812 | 2.68B |
| 79 | COO | The Cooper Companies, Inc. | 13.03B | -0.82% | 6,932,527 | 4.23B |
| 80 | EXEL | Exelixis, Inc. | 13.01B | -1.82% | 1,918,093 | 2.38B |
| 81 | SNN | Smith & Nephew plc | 12.98B | -0.88% | 1,003,026 | 6.16B |
| 82 | ASND | Ascendis Pharma A/S | 12.78B | -2.20% | 1,092,182 | 998.25M |
| 83 | PEN | Penumbra, Inc. | 12.59B | -0.14% | 279,261 | 1.45B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 12.34B | 3.17% | 4,186,131 | 13.65B |
| 85 | DVA | DaVita Inc. | 12.33B | -0.04% | 667,969 | 13.84B |
| 86 | ALGN | Align Technology, Inc. | 12.32B | 2.57% | 955,256 | 4.10B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 12.15B | -1.26% | 1,620,587 | 1.06B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.10B | 1.21% | 548,844 | 708.24M |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.83B | 0.21% | 5,272,598 | 4.89B |
| 90 | FMS | Fresenius Medical Care AG | 11.77B | -1.09% | 478,897 | 22.32B |
| 91 | ICLR | ICON Public Limited Company | 11.66B | 1.87% | 1,129,031 | 8.25B |
| 92 | RVTY | Revvity, Inc. | 11.19B | 1.96% | 1,280,406 | 2.90B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.12B | -0.08% | 1,370,687 | 3.58B |
| 94 | SMMT | Summit Therapeutics Inc. | 10.95B | -4.47% | 5,493,014 | - |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 10.93B | -0.39% | 2,062,949 | 3.24B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.77B | -4.05% | 262,727 | 1.13B |
| 97 | GMED | Globus Medical, Inc. | 10.63B | -2.13% | 1,613,413 | 3.10B |
| 98 | RGC | Regencell Bioscience Holdings Limited | 10.60B | 7.00% | 123,770 | - |
| 99 | PODD | Insulet Corporation | 10.49B | -1.12% | 1,569,586 | 2.90B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.40B | 1.05% | 1,204,680 | 622.01M |
| 101 | MOH | Molina Healthcare, Inc. | 10.34B | 3.96% | 1,023,581 | 43.10B |
| 102 | EHC | Encompass Health Corporation | 10.03B | -2.79% | 734,943 | 6.07B |
| 103 | BAX | Baxter International Inc. | 9.94B | -0.72% | 5,044,209 | 11.32B |
| 104 | MASI | Masimo Corporation | 9.42B | 0.63% | 1,267,169 | 1.56B |
| 105 | CYTK | Cytokinetics, Incorporated | 9.22B | -5.01% | 2,382,329 | 105.82M |
| 106 | ENSG | The Ensign Group, Inc. | 9.07B | -8.15% | 2,348,447 | 5.27B |
| 107 | CRL | Charles River Laboratories International, Inc. | 8.98B | 2.81% | 761,633 | 4.03B |
| 108 | KRYS | Krystal Biotech, Inc. | 8.90B | 0.25% | 259,661 | 417.30M |
| 109 | HSIC | Henry Schein, Inc. | 8.89B | 0.77% | 1,177,748 | 13.38B |
| 110 | TEM | Tempus AI, Inc. | 8.73B | 4.65% | 4,832,127 | 1.36B |
| 111 | UHS | Universal Health Services, Inc. | 8.65B | -1.45% | 1,379,160 | 17.76B |
| 112 | BRKR | Bruker Corporation | 8.56B | -0.23% | 2,732,695 | 3.46B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.39B | -1.12% | 1,496,609 | 1.51B |
| 114 | OSCR | Oscar Health, Inc. | 8.25B | 11.75% | 14,958,770 | 13.30B |
| 115 | TECH | Bio-Techne Corporation | 8.24B | 1.27% | 4,439,998 | 1.21B |
| 116 | ABVX | ABIVAX Société Anonyme | 8.20B | - | 1,821,837 | 5.67M |
| 117 | CORT | Corcept Therapeutics Incorporated | 7.87B | 0.98% | 867,327 | 769.10M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.80B | -1.02% | 430,962 | 2.59B |
| 119 | IBRX | ImmunityBio, Inc. | 7.51B | 3.61% | 11,386,905 | 140.98M |
| 120 | QGEN | Qiagen N.V. | 7.49B | -1.23% | 1,485,699 | 2.10B |
| 121 | HQY | HealthEquity, Inc. | 7.34B | -0.94% | 970,553 | 1.34B |
| 122 | GKOS | Glaukos Corporation | 7.16B | -2.43% | 962,156 | 551.35M |
| 123 | ATR | AptarGroup, Inc. | 7.14B | -1.25% | 422,153 | 3.87B |
| 124 | ALKS | Alkermes plc | 7.08B | -0.82% | 1,292,143 | 1.56B |
| 125 | RGEN | Repligen Corporation | 7.07B | 2.47% | 740,959 | 763.34M |
| 126 | PRAX | Praxis Precision Medicines, Inc. | 7.06B | -0.30% | 679,808 | 7.46M |
| 127 | NUVL | Nuvalent, Inc. | 6.99B | -2.70% | 1,074,668 | - |
| 128 | PCVX | Vaxcyte, Inc. | 6.69B | -2.17% | 1,341,175 | - |
| 129 | AVTR | Avantor, Inc. | 6.62B | 5.79% | 17,367,169 | 6.55B |
| 130 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.96% | 751,533 | 1.55B |
| 131 | IMVT | Immunovant, Inc. | 6.32B | -1.00% | 1,015,535 | - |
| 132 | GRFS | Grifols, S.A. | 6.32B | -4.06% | 569,429 | 8.58B |
| 133 | PTGX | Protagonist Therapeutics, Inc. | 6.30B | 0.67% | 567,714 | 74.06M |
| 134 | HIMS | Hims & Hers Health, Inc. | 6.29B | 3.74% | 13,842,635 | 2.37B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.25B | -2.24% | 1,035,946 | - |
| 136 | APGE | Apogee Therapeutics, Inc. | 6.22B | -4.50% | 1,304,571 | - |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.14B | 0.20% | 553,274 | 15.00M |
| 138 | KYMR | Kymera Therapeutics, Inc. | 6.08B | -0.24% | 453,688 | 51.48M |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.89B | -0.55% | 483,151 | 217.17M |
| 140 | PTCT | PTC Therapeutics, Inc. | 5.88B | -0.14% | 1,293,284 | 827.11M |
| 141 | LEGN | Legend Biotech Corporation | 5.85B | -3.37% | 3,203,461 | 1.14B |
| 142 | TFX | Teleflex Incorporated | 5.83B | 1.46% | 413,339 | 2.13B |
| 143 | CHE | Chemed Corporation | 5.81B | -0.56% | 186,576 | 2.54B |
| 144 | TGTX | TG Therapeutics, Inc. | 5.80B | 1.97% | 1,555,840 | 700.35M |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | 0.11% | 473,319 | 569.61M |
| 146 | LQDA | Liquidia Corporation | 5.68B | 3.31% | 3,159,499 | 288.07M |
| 147 | PACS | PACS Group, Inc. | 5.55B | -5.24% | 1,213,673 | 5.43B |
| 148 | BLTE | Belite Bio, Inc | 5.49B | -2.60% | 153,178 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 5.41B | -1.81% | 381,116 | 5.21B |
| 150 | COGT | Cogent Biosciences, Inc. | 5.33B | 0.45% | 1,901,361 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.25B | -1.13% | 811,956 | - |
| 152 | CRSP | CRISPR Therapeutics AG | 4.98B | -0.46% | 1,131,312 | 4.10M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 4.95B | -1.01% | 1,180,969 | 7.50M |
| 154 | STVN | Stevanato Group S.p.A. | 4.91B | -2.49% | 233,521 | 1.39B |
| 155 | HNGE | Hinge Health, Inc. | 4.86B | -1.19% | 1,674,359 | 646.34M |
| 156 | CGON | CG Oncology, Inc. | 4.80B | 1.27% | 828,325 | 5.07M |
| 157 | LGND | Ligand Pharmaceuticals Incorporated | 4.76B | 0.32% | 219,150 | 274.48M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.56B | -2.12% | 3,402,995 | 907.29M |
| 159 | SHC | Sotera Health Company | 4.52B | 1.54% | 2,447,909 | 1.19B |
| 160 | TNGX | Tango Therapeutics, Inc. | 4.47B | 52.97% | 21,825,741 | 56.99M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 0.88% | 559,562 | 1.34M |
| 162 | TVTX | Travere Therapeutics, Inc. | 4.38B | 2.77% | 1,943,769 | 536.20M |
| 163 | AMRX | Amneal Pharmaceuticals, Inc. | 4.37B | -0.29% | 1,394,657 | 3.05B |
| 164 | TWST | Twist Bioscience Corporation | 4.36B | 1.18% | 1,395,019 | 409.48M |
| 165 | BLLN | BillionToOne, Inc. | 4.34B | -2.84% | 773,433 | 354.54M |
| 166 | CELC | Celcuity Inc. | 4.26B | -0.96% | 1,437,721 | - |
| 167 | RDNT | RadNet, Inc. | 4.26B | -0.33% | 556,243 | 2.14B |
| 168 | MMED | MiniMed Group, Inc. | 4.18B | 4.57% | 742,198 | 3.10B |
| 169 | LIVN | LivaNova PLC | 4.11B | 3.37% | 797,776 | 1.43B |
| 170 | ERAS | Erasca, Inc. | 4.00B | 7.52% | 5,856,674 | - |
| 171 | MMSI | Merit Medical Systems, Inc. | 3.94B | 2.40% | 1,176,356 | 1.54B |
| 172 | ORKA | Oruka Therapeutics, Inc. | 3.86B | 6.52% | 1,086,603 | - |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.03% | 1,589,008 | 596.96M |
| 174 | NVST | Envista Holdings Corporation | 3.81B | 1.47% | 3,325,226 | 2.81B |
| 175 | MANE | Veradermics, Incorporated | 3.77B | -1.49% | 425,649 | - |
| 176 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.77B | 1.28% | 443,892 | 754.05M |
| 177 | VCYT | Veracyte, Inc. | 3.77B | -3.00% | 1,045,850 | 541.74M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 3.75B | -2.11% | 1,139,904 | - |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 0.65% | 883,774 | 1.10B |
| 180 | DOCS | Doximity, Inc. | 3.71B | -1.41% | 2,789,688 | 644.86M |
| 181 | TXG | 10x Genomics, Inc. | 3.70B | -5.99% | 3,106,678 | 638.78M |
| 182 | WAY | Waystar Holding Corp. | 3.64B | -5.10% | 3,291,843 | 1.16B |
| 183 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | -1.81% | 512,930 | 22.57M |
| 184 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.53B | 1.70% | 993,833 | 18.07M |
| 185 | IRTC | iRhythm Holdings, Inc. | 3.52B | -0.81% | 573,116 | 787.85M |
| 186 | OGN | Organon & Co. | 3.52B | 0.22% | 2,759,300 | 6.16B |
| 187 | ICUI | ICU Medical, Inc. | 3.44B | 0.64% | 296,737 | 2.16B |
| 188 | HAE | Haemonetics Corporation | 3.40B | 5.05% | 1,343,232 | 1.33B |
| 189 | VKTX | Viking Therapeutics, Inc. | 3.39B | 2.78% | 2,096,390 | - |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.26B | 0.55% | 563,048 | 2.23B |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.19B | -0.81% | 98,897 | 803.79M |
| 192 | ALHC | Alignment Healthcare, Inc. | 3.17B | -0.13% | 4,528,018 | 4.26B |
| 193 | OPCH | Option Care Health, Inc. | 3.15B | -2.10% | 3,053,625 | 5.67B |
| 194 | ITGR | Integer Holdings Corporation | 3.12B | -0.10% | 216,435 | 1.86B |
| 195 | DNLI | Denali Therapeutics Inc. | 3.10B | 0.10% | 1,893,414 | - |
| 196 | RLAY | Relay Therapeutics, Inc. | 2.98B | 1.04% | 2,908,199 | 10.68M |
| 197 | BEAM | Beam Therapeutics Inc. | 2.96B | 1.29% | 1,311,629 | 164.01M |
| 198 | RCUS | Arcus Biosciences, Inc. | 2.93B | 0.56% | 812,214 | 236.00M |
| 199 | NHC | National HealthCare Corporation | 2.93B | -2.29% | 151,839 | 1.53B |
| 200 | WRBY | Warby Parker Inc. | 2.89B | 3.48% | 3,637,743 | 890.57M |
| 201 | LFST | LifeStance Health Group, Inc. | 2.85B | -0.94% | 2,109,578 | 1.49B |
| 202 | BKD | Brookdale Senior Living Inc. | 2.83B | -3.81% | 5,092,366 | 3.00B |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.78B | -1.35% | 2,058,344 | - |
| 204 | IDYA | IDEAYA Biosciences, Inc. | 2.77B | 11.28% | 2,580,752 | 225.27M |
| 205 | PRVA | Privia Health Group, Inc. | 2.70B | -1.02% | 975,623 | 2.25B |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 2.69B | 1.46% | 1,120,752 | 415.62M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.68B | 0.51% | 764,704 | - |
| 208 | ADPT | Adaptive Biotechnologies Corporation | 2.67B | -1.18% | 1,749,310 | 295.41M |
| 209 | GRAL | GRAIL, Inc. | 2.64B | 2.57% | 659,432 | 156.12M |
| 210 | SUPN | Supernus Pharmaceuticals, Inc. | 2.58B | -0.41% | 431,264 | 776.83M |
| 211 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 0.61% | 443,376 | 535.08M |
| 212 | GRDN | Guardian Pharmacy Services, Inc. | 2.57B | 0.07% | 309,498 | 1.46B |
| 213 | KLRA | Kailera Therapeutics, Inc. | 2.55B | 1.70% | 722,560 | - |
| 214 | IRON | Disc Medicine, Inc. | 2.51B | -1.79% | 711,479 | - |
| 215 | DFTX | Definium Therapeutics, Inc. | 2.51B | -2.25% | 3,644,685 | - |
| 216 | TMDX | TransMedics Group, Inc. | 2.46B | 2.46% | 1,121,614 | 635.89M |
| 217 | HTFL | HeartFlow, Inc. | 2.45B | 1.25% | 667,910 | 191.42M |
| 218 | ALMS | Alumis Inc. | 2.42B | -0.37% | 1,711,868 | 8.40M |
| 219 | GMRS | GMR Solutions Inc. | 2.36B | -2.94% | 450,320 | 5.83B |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.33B | 3.43% | 1,380,132 | 3.37B |
| 221 | VERA | Vera Therapeutics, Inc. | 2.28B | -1.67% | 698,868 | - |
| 222 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | 1.14% | 665,140 | 1.09B |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.24B | -0.21% | 629,704 | 865.00K |
| 224 | AXGN | Axogen, Inc. | 2.20B | -3.13% | 1,104,799 | 238.11M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.20B | 0.71% | 474,206 | 229.58M |
| 226 | PHVS | Pharvaris N.V. | 2.20B | 1.61% | 552,721 | - |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.17B | 0.67% | 244,052 | 256.28M |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.14B | 0.24% | 4,085,979 | 885.72M |
| 229 | RARE | Ultragenyx Pharmaceutical Inc. | 2.12B | -1.46% | 1,689,266 | 670.00M |
| 230 | IMNM | Immunome, Inc. | 2.11B | 0.16% | 1,094,630 | 4.02M |
| 231 | CLOV | Clover Health Investments, Corp. | 2.06B | 2.35% | 4,179,237 | 2.21B |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.06B | 2.60% | 4,799,950 | 3.68B |
| 233 | SEM | Select Medical Holdings Corporation | 2.05B | 0.18% | 1,634,687 | 5.52B |
| 234 | ELVN | Enliven Therapeutics, Inc. | 2.05B | -3.11% | 834,212 | - |
| 235 | PGNY | Progyny, Inc. | 2.03B | 0.23% | 1,612,886 | 1.29B |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -1.14% | 783,617 | 298.30M |
| 237 | NEOG | Neogen Corporation | 1.97B | 1.91% | 1,626,019 | 870.56M |
| 238 | NVCR | NovoCure Limited | 1.95B | -1.81% | 1,178,797 | 674.41M |
| 239 | TRVI | Trevi Therapeutics, Inc. | 1.92B | 1.28% | 697,508 | - |
| 240 | NKTR | Nektar Therapeutics | 1.91B | -1.22% | 1,000,137 | 55.63M |
| 241 | BHC | Bausch Health Companies Inc. | 1.91B | -4.84% | 1,855,383 | 10.53B |
| 242 | OMCL | Omnicell, Inc. | 1.91B | -2.44% | 583,754 | 1.23B |
| 243 | ASTH | Astrana Health, Inc. | 1.90B | 1.05% | 434,455 | 3.53B |
| 244 | HCM | HUTCHMED (China) Limited | 1.89B | -0.18% | 36,564 | 548.51M |
| 245 | NTLA | Intellia Therapeutics, Inc. | 1.88B | -0.37% | 3,420,275 | 66.09M |
| 246 | MESO | Mesoblast Limited | 1.88B | -1.08% | 181,580 | 65.38M |
| 247 | HRMY | Harmony Biosciences Holdings, Inc. | 1.88B | 0.67% | 479,726 | 899.11M |
| 248 | ADMA | ADMA Biologics, Inc. | 1.87B | 1.13% | 2,603,331 | 509.86M |
| 249 | MLYS | Mineralys Therapeutics, Inc. | 1.86B | -5.02% | 2,021,812 | - |
| 250 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -0.68% | 214,701 | 1.20B |
| 251 | ZLAB | Zai Lab Limited | 1.85B | -0.84% | 1,084,399 | 453.28M |
| 252 | KOD | Kodiak Sciences Inc. | 1.85B | -4.64% | 822,219 | - |
| 253 | VCEL | Vericel Corporation | 1.83B | -1.46% | 371,973 | 292.09M |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.81B | -3.37% | 331,442 | 32.08M |
| 255 | MD | Pediatrix Medical Group, Inc. | 1.80B | -0.62% | 683,121 | 1.93B |
| 256 | NBTX | Nanobiotix S.A. | 1.80B | 0.76% | 25,977 | 38.27M |
| 257 | SGRY | Surgery Partners, Inc. | 1.80B | 1.06% | 720,300 | 3.34B |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.79B | -1.09% | 1,502,296 | 52.04M |
| 259 | IOVA | Iovance Biotherapeutics, Inc. | 1.79B | -5.44% | 11,285,622 | 285.61M |
| 260 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 0.15% | 15,796,647 | 66.41M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 1.75B | 1.61% | 151,244 | 20.00M |
| 262 | UFPT | UFP Technologies, Inc. | 1.75B | 1.27% | 163,253 | 608.85M |
| 263 | ZYME | Zymeworks Inc. | 1.75B | -0.46% | 553,167 | 81.26M |
| 264 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -0.32% | 1,096,875 | 70.92M |
| 265 | PLSE | Pulse Biosciences, Inc. | 1.72B | -1.93% | 242,314 | 751.00K |
| 266 | QURE | uniQure N.V. | 1.70B | 2.08% | 761,116 | 18.09M |
| 267 | ANIP | ANI Pharmaceuticals, Inc. | 1.70B | -1.21% | 251,833 | 923.71M |
| 268 | BHVN | Biohaven Ltd. | 1.67B | 2.96% | 2,281,301 | - |
| 269 | NUVB | Nuvation Bio Inc. | 1.67B | -0.41% | 2,964,607 | 143.05M |
| 270 | ADUS | Addus HomeCare Corporation | 1.66B | -1.51% | 184,279 | 1.45B |
| 271 | ABCL | AbCellera Biologics Inc. | 1.65B | -3.56% | 4,784,974 | 79.21M |
| 272 | INVA | Innoviva, Inc. | 1.65B | -0.84% | 913,452 | 420.69M |
| 273 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | -1.27% | 2,425,796 | 2.18B |
| 274 | GENB | Generate Biomedicines, Inc. | 1.64B | -0.70% | 817,347 | 30.30M |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | -2.97% | 520,708 | 66.05M |
| 276 | NRIX | Nurix Therapeutics, Inc. | 1.62B | 6.83% | 21,065,182 | 71.78M |
| 277 | PRCT | PROCEPT BioRobotics Corporation | 1.61B | 1.87% | 1,312,572 | 322.02M |
| 278 | PRGO | Perrigo Company plc | 1.61B | 7.20% | 5,012,962 | 4.18B |
| 279 | TYRA | Tyra Biosciences, Inc. | 1.59B | 0.41% | 1,198,481 | - |
| 280 | AGL | agilon health, inc. | 1.59B | -1.57% | 253,484 | 5.82B |
| 281 | AAPG | Ascentage Pharma Group International | 1.59B | -0.47% | 3,211 | 82.08M |
| 282 | CMPS | COMPASS Pathways plc | 1.58B | -3.14% | 3,102,218 | - |
| 283 | FTRE | Fortrea Holdings Inc. | 1.57B | 3.05% | 1,186,698 | 2.71B |
| 284 | SNDA | Sonida Senior Living, Inc. | 1.56B | -2.59% | 653,005 | 367.34M |
| 285 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -1.27% | 3,501,809 | 7.47M |
| 286 | WGS | GeneDx Holdings Corp. | 1.54B | -0.79% | 795,921 | 442.68M |
| 287 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -2.06% | 640,671 | 11.13M |
| 288 | SION | Sionna Therapeutics, Inc. | 1.51B | -5.26% | 423,758 | - |
| 289 | PVLA | Palvella Therapeutics, Inc. | 1.51B | -3.15% | 368,318 | - |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.50B | -2.19% | 2,338,407 | 217.17M |
| 291 | ANAB | AnaptysBio, Inc. | 1.49B | 1.97% | 384,539 | 232.39M |
| 292 | STAA | STAAR Surgical Company | 1.49B | -0.10% | 679,812 | 290.38M |
| 293 | SLS | SELLAS Life Sciences Group, Inc. | 1.48B | -3.04% | 5,887,226 | - |
| 294 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.45B | -2.33% | 2,093,573 | -665.00K |
| 295 | AVAH | Aveanna Healthcare Holdings Inc. | 1.45B | -0.60% | 1,700,393 | 2.52B |
| 296 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | 0.15% | 1,844,273 | 114.48M |
| 297 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 3.85% | 2,046,148 | 42.95M |
| 298 | NEO | NeoGenomics, Inc. | 1.43B | 0.46% | 1,175,603 | 745.97M |
| 299 | VIR | Vir Biotechnology, Inc. | 1.43B | -2.31% | 1,332,806 | 65.50M |
| 300 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 0.49% | 438,234 | - |
| 301 | NVAX | Novavax, Inc. | 1.42B | -9.17% | 6,864,237 | 596.34M |
| 302 | IMCR | Immunocore Holdings plc | 1.41B | -1.77% | 454,160 | 412.81M |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.41B | 0.79% | 437,754 | 1.85B |
| 304 | ATAI | AtaiBeckley Inc. | 1.40B | -3.54% | 4,929,036 | 3.49M |
| 305 | GHRS | GH Research PLC | 1.38B | -6.11% | 379,047 | - |
| 306 | MBX | MBX Biosciences, Inc. | 1.38B | -4.23% | 739,110 | - |
| 307 | SEPN | Septerna, Inc. | 1.37B | -2.38% | 327,215 | 72.26M |
| 308 | ARDX | Ardelyx, Inc. | 1.37B | -0.36% | 1,817,292 | 427.68M |
| 309 | ENOV | Enovis Corporation | 1.36B | -0.42% | 694,147 | 2.28B |
| 310 | ATRC | AtriCure, Inc. | 1.36B | -0.68% | 559,543 | 552.16M |
| 311 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 5.18% | 235,071 | - |
| 312 | ALMR | Alamar Biosciences, Inc. | 1.33B | -6.48% | 198,055 | 87.16M |
| 313 | URGN | UroGen Pharma Ltd. | 1.33B | 1.49% | 671,594 | 140.49M |
| 314 | ALVO | Alvotech | 1.33B | 19.77% | 2,265,888 | 562.04M |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.56% | 1,213,598 | - |
| 316 | BCAX | Bicara Therapeutics Inc. | 1.32B | 0.50% | 478,295 | - |
| 317 | IART | Integra LifeSciences Holdings Corporation | 1.32B | -0.29% | 927,800 | 1.64B |
| 318 | INBX | Inhibrx Biosciences, Inc. | 1.31B | 2.44% | 194,457 | 1.30M |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.31B | -2.84% | 449,048 | 20.00M |
| 320 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.30B | 0.40% | 2,807,795 | 204.73M |
| 321 | PAHC | Phibro Animal Health Corporation | 1.29B | -2.07% | 267,719 | 1.50B |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.29B | -0.48% | 302,088 | - |
| 323 | AHCO | AdaptHealth Corp. | 1.28B | -2.43% | 908,026 | 3.29B |
| 324 | SVRA | Savara Inc. | 1.28B | -0.59% | 920,545 | - |
| 325 | TDOC | Teladoc Health, Inc. | 1.28B | 0.43% | 2,758,638 | 2.51B |
| 326 | BLFS | BioLife Solutions, Inc. | 1.28B | -2.06% | 456,506 | 101.66M |
| 327 | PGEN | Precigen, Inc. | 1.27B | -0.28% | 4,630,105 | 31.60M |
| 328 | ARDT | Ardent Health, Inc. | 1.27B | 1.73% | 901,965 | 6.43B |
| 329 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | -4.50% | 2,994,995 | 1.03B |
| 330 | BFLY | Butterfly Network, Inc. | 1.25B | 4.60% | 4,454,220 | 102.92M |
| 331 | IMTX | Immatics N.V. | 1.24B | -5.82% | 339,686 | 43.00M |
| 332 | HROW | Harrow, Inc. | 1.23B | -0.27% | 761,649 | 268.68M |
| 333 | ATEC | Alphatec Holdings, Inc. | 1.22B | -1.12% | 1,736,289 | 787.08M |
| 334 | INSP | Inspire Medical Systems, Inc. | 1.21B | 1.82% | 732,671 | 915.25M |
| 335 | IRMD | IRADIMED CORPORATION | 1.21B | 1.42% | 93,410 | 86.28M |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.20B | -2.05% | 1,137,627 | 3.42B |
| 337 | AVLN | Avalyn Pharma Inc. | 1.17B | 3.70% | 272,288 | - |
| 338 | AVNS | Avanos Medical, Inc. | 1.17B | -0.20% | 894,659 | 715.90M |
| 339 | KMTS | Kestra Medical Technologies, Ltd. | 1.15B | 1.86% | 275,026 | 83.72M |
| 340 | AHG | Akso Health Group | 1.14B | -0.75% | 17,371 | 14.84M |
| 341 | CDNA | CareDx, Inc. | 1.13B | -1.35% | 366,042 | 412.82M |
| 342 | COAG | Hemab Therapeutics Holdings, Inc. | 1.13B | 0.99% | 202,389 | - |
| 343 | ZBIO | Zenas BioPharma, Inc. | 1.11B | 0.80% | 504,605 | 10.00M |
| 344 | WVE | Wave Life Sciences Ltd. | 1.10B | -0.52% | 3,340,637 | 71.80M |
| 345 | PNTG | The Pennant Group, Inc. | 1.09B | -1.04% | 164,714 | 1.02B |
| 346 | OPK | OPKO Health, Inc. | 1.08B | -0.69% | 1,938,115 | 581.12M |
| 347 | COLL | Collegium Pharmaceutical, Inc. | 1.08B | -0.36% | 422,374 | 796.33M |
| 348 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | 0.97% | 864,489 | 314.85M |
| 349 | SDGR | Schrödinger, Inc. | 1.08B | 0.14% | 866,302 | 254.91M |
| 350 | OMDA | Omada Health, Inc. | 1.06B | -0.28% | 587,644 | 283.30M |
| 351 | PSNL | Personalis, Inc. | 1.05B | -6.60% | 2,341,492 | 64.52M |
| 352 | AKTS | Aktis Oncology, Inc. | 1.05B | 0.53% | 155,614 | 8.28M |
| 353 | MNKD | MannKind Corporation | 1.05B | -0.29% | 2,349,399 | 360.78M |
| 354 | AZTA | Azenta, Inc. | 1.05B | 0.09% | 832,149 | 596.48M |
| 355 | CRON | Cronos Group Inc. | 1.04B | 1.09% | 1,209,676 | 159.54M |
| 356 | CNMD | CONMED Corporation | 1.04B | -1.91% | 456,053 | 1.37B |
| 357 | ABSI | Absci Corporation | 1.02B | 2.34% | 2,748,353 | 1.84M |
| 358 | EVO | Evotec SE | 1.01B | 0.36% | 32,389 | 859.03M |
| 359 | INNV | InnovAge Holding Corp. | 1.00B | 0.96% | 338,039 | 949.17M |
| 360 | AORT | Artivion, Inc. | 989.80M | 1.34% | 816,993 | 458.69M |
| 361 | QDEL | QuidelOrtho Corporation | 986.38M | 0.94% | 1,363,399 | 2.66B |
| 362 | DBVT | DBV Technologies S.A. | 970.44M | -3.56% | 178,466 | 5.74M |
| 363 | EYPT | EyePoint, Inc. | 959.98M | -2.80% | 805,677 | 7.61M |
| 364 | AVR | Anteris Technologies Global Corp. | 949.88M | -3.11% | 1,005,849 | 1.85M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 937.61M | 0.27% | 915,307 | - |
| 366 | USPH | U.S. Physical Therapy, Inc. | 932.91M | -3.39% | 218,949 | 787.69M |
| 367 | NUTX | Nutex Health Inc. | 924.92M | 1.37% | 108,139 | 879.95M |
| 368 | PHAR | Pharming Group N.V. | 906.06M | 2.07% | 9,399 | 369.49M |
| 369 | PCRX | Pacira BioSciences, Inc. | 899.49M | 0.48% | 386,663 | 734.86M |
| 370 | SPRY | ARS Pharmaceuticals, Inc. | 892.74M | 5.02% | 1,909,593 | 98.99M |
| 371 | GDRX | GoodRx Holdings, Inc. | 890.72M | -0.75% | 761,287 | 787.89M |
| 372 | JBIO | Jade Biosciences, Inc. | 889.21M | -11.57% | 1,466,299 | - |
| 373 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,681,555 | 238.37M |
| 374 | OLMA | Olema Pharmaceuticals, Inc. | 869.98M | -3.39% | 1,377,509 | - |
| 375 | SPTX | Seaport Therapeutics, Inc. | 859.05M | -1.46% | 109,683 | - |
| 376 | INMD | InMode Ltd. | 855.34M | -0.30% | 426,090 | 374.64M |
| 377 | AMPH | Amphastar Pharmaceuticals, Inc. | 854.96M | -1.77% | 558,989 | 720.53M |
| 378 | XNCR | Xencor, Inc. | 845.96M | -3.06% | 776,151 | 97.36M |
| 379 | LBRX | LB Pharmaceuticals Inc | 843.09M | 3.05% | 99,811 | - |
| 380 | MGTX | MeiraGTx Holdings plc | 841.82M | 1.00% | 479,171 | 79.76M |
| 381 | TBPH | Theravance Biopharma, Inc. | 839.80M | - | 227,071 | 109.78M |
| 382 | ANNX | Annexon, Inc. | 838.87M | -3.21% | 3,315,505 | - |
| 383 | ABUS | Arbutus Biopharma Corporation | 837.56M | -0.24% | 747,465 | 191.45M |
| 384 | DRTS | Alpha Tau Medical Ltd. | 836.83M | -0.75% | 598,282 | - |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 835.09M | -1.57% | 1,489,320 | 69.64M |
| 386 | JANX | Janux Therapeutics, Inc. | 823.90M | 1.12% | 639,910 | 13.73M |
| 387 | ETON | Eton Pharmaceuticals, Inc. | 820.40M | 2.81% | 498,947 | 86.93M |
| 388 | IVA | Inventiva S.A. | 819.08M | -2.98% | 313,966 | 7.94M |
| 389 | CGEM | Cullinan Therapeutics, Inc. | 816.16M | -1.70% | 1,741,175 | - |
| 390 | CERT | Certara, Inc. | 812.05M | -2.79% | 6,074,928 | 419.75M |
| 391 | ESPR | Esperion Therapeutics, Inc. | 810.91M | 0.64% | 11,339,329 | 418.24M |
| 392 | ODTX | Odyssey Therapeutics, Inc. | 807.62M | 4.20% | 197,785 | 2.98M |
| 393 | PHAT | Phathom Pharmaceuticals, Inc. | 794.30M | -1.28% | 720,373 | 204.89M |
| 394 | LMRI | Lumexa Imaging Holdings, Inc. | 781.14M | -4.35% | 1,707,827 | 1.03B |
| 395 | ORIC | ORIC Pharmaceuticals, Inc. | 779.49M | 0.40% | 1,762,025 | - |
| 396 | KURA | Kura Oncology, Inc. | 759.91M | -2.06% | 1,426,423 | 71.64M |
| 397 | NNNN | Anbio Biotechnology | 755.81M | -25.10% | 61,296 | 8.65M |
| 398 | HSTM | HealthStream, Inc. | 749.37M | 1.62% | 199,770 | 311.78M |
| 399 | SANA | Sana Biotechnology, Inc. | 748.60M | 0.37% | 3,344,197 | - |
| 400 | BVS | Bioventus Inc. | 747.64M | -1.00% | 485,212 | 576.30M |
| 401 | REPL | Replimune Group, Inc. | 740.68M | -5.28% | 3,142,785 | - |
| 402 | EVMN | Evommune, Inc. | 727.21M | 1.36% | 335,740 | 10.00M |
| 403 | GERN | Geron Corporation | 724.92M | -3.42% | 11,184,518 | 196.12M |
| 404 | VOR | Vor Biopharma Inc. | 720.13M | 0.99% | 871,173 | - |
| 405 | AURA | Aura Biosciences, Inc. | 714.74M | -2.26% | 248,432 | - |
| 406 | ZVRA | Zevra Therapeutics, Inc. | 714.70M | 13.95% | 3,529,016 | 122.29M |
| 407 | OMER | Omeros Corporation | 712.90M | 0.61% | 1,407,384 | 9.89M |
| 408 | SSII | SS Innovations International, Inc. | 705.79M | -6.61% | 79,397 | 48.47M |
| 409 | BIOA | BioAge Labs, Inc. | 689.46M | -1.21% | 304,780 | 10.32M |
| 410 | CBLL | CeriBell, Inc. | 688.28M | -0.60% | 277,783 | 95.07M |
| 411 | CRMD | CorMedix Inc. | 669.98M | 2.15% | 1,822,336 | 400.05M |
| 412 | AVTX | Avalo Therapeutics, Inc. | 669.69M | -2.75% | 1,044,930 | 59.00K |
| 413 | SIBN | SI-BONE, Inc. | 663.91M | -0.99% | 350,701 | 206.22M |
| 414 | DSGN | Design Therapeutics, Inc. | 653.30M | -1.78% | 700,056 | - |
| 415 | OCS | Oculis Holding AG | 646.76M | -4.46% | 1,468,523 | 1.40M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 640.05M | -2.00% | 3,643,560 | 35.54M |
| 417 | ANRO | Alto Neuroscience, Inc. | 639.36M | -0.11% | 515,535 | - |
| 418 | ALLO | Allogene Therapeutics, Inc. | 638.54M | -1.60% | 9,264,074 | 22.00K |
| 419 | SLDB | Solid Biosciences Inc. | 631.06M | -4.33% | 862,700 | - |
| 420 | DRUG | Bright Minds Biosciences Inc. | 629.81M | -5.39% | 352,609 | - |
| 421 | SGP | SpyGlass Pharma, Inc. | 625.75M | -0.32% | 77,196 | - |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 623.23M | -0.38% | 206,708 | - |
| 423 | CADL | Candel Therapeutics, Inc. | 622.80M | -0.12% | 1,508,846 | - |
| 424 | TENX | Tenax Therapeutics, Inc. | 620.58M | -1.77% | 588,061 | - |
| 425 | BBNX | Beta Bionics, Inc. | 618.07M | -0.14% | 1,263,532 | 110.24M |
| 426 | CSTL | Castle Biosciences, Inc. | 610.24M | -4.24% | 247,967 | 339.92M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 608.93M | - | 1,464,030 | 8.37M |
| 428 | TLRY | Tilray Brands, Inc. | 599.99M | 1.82% | 3,843,517 | 858.28M |
| 429 | RLMD | Relmada Therapeutics, Inc. | 599.97M | -3.87% | 1,575,384 | - |
| 430 | PHR | Phreesia, Inc. | 577.32M | -2.10% | 952,932 | 495.59M |
| 431 | CBIO | Crescent Biopharma, Inc. | 574.20M | -4.00% | 238,263 | 11.88M |
| 432 | BWAY | BrainsWay Ltd. | 573.62M | 3.74% | 68,146 | 56.22M |
| 433 | TCMD | Tactile Systems Technology, Inc. | 569.55M | -0.59% | 202,667 | 343.52M |
| 434 | ACHV | Achieve Life Sciences, Inc. | 562.57M | 6.82% | 1,107,736 | - |
| 435 | RIGL | Rigel Pharmaceuticals, Inc. | 556.54M | 0.50% | 187,387 | 299.77M |
| 436 | GYRE | Gyre Therapeutics, Inc. | 552.80M | -3.82% | 76,626 | 117.05M |
| 437 | MDXG | MiMedx Group, Inc. | 551.10M | -1.07% | 1,088,762 | 389.42M |
| 438 | TRAX | First Tracks Biotherapeutics, Inc. | 549.56M | -5.12% | 674,557 | - |
| 439 | IMMX | Immix Biopharma, Inc. | 549.25M | -0.76% | 1,081,390 | - |
| 440 | TECX | Tectonic Therapeutic, Inc. | 549.09M | 0.34% | 84,400 | - |
| 441 | IRWD | Ironwood Pharmaceuticals, Inc. | 541.58M | -0.60% | 1,502,088 | 361.51M |
| 442 | PRME | Prime Medicine, Inc. | 534.63M | -3.27% | 2,459,803 | 4.03M |
| 443 | NPCE | NeuroPace, Inc. | 532.89M | -0.70% | 104,225 | 99.53M |
| 444 | ALT | Altimmune, Inc. | 530.91M | 0.74% | 2,172,837 | 36.00K |
| 445 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.48M | -1.58% | 821,245 | 151.40M |
| 446 | XOMA | XOMA Royalty Corporation | 525.72M | -0.40% | 107,413 | 48.56M |
| 447 | EVH | Evolent Health, Inc. | 524.16M | 10.43% | 3,510,615 | 1.89B |
| 448 | CABA | Cabaletta Bio, Inc. | 521.78M | -1.54% | 2,977,573 | - |
| 449 | CTKB | Cytek Biosciences, Inc. | 521.74M | -1.22% | 1,413,312 | 204.17M |
| 450 | CERS | Cerus Corporation | 520.96M | -4.06% | 1,672,872 | 216.56M |
| 451 | FLGT | Fulgent Genetics, Inc. | 520.02M | -4.39% | 333,978 | 320.35M |
| 452 | PROK | ProKidney Corp. | 516.52M | -5.00% | 998,725 | 889.00K |
| 453 | CLYM | Climb Bio, Inc. | 514.47M | 2.09% | 2,228,467 | - |
| 454 | SRTA | Strata Critical Medical, Inc. | 507.91M | 1.38% | 774,282 | 228.58M |
| 455 | AGMB | AgomAb Therapeutics NV | 507.75M | 3.93% | 304,407 | - |
| 456 | TOI | The Oncology Institute, Inc. | 506.91M | 4.11% | 3,011,364 | 545.76M |
| 457 | VALN | Valneva SE | 506.31M | -2.65% | 22,376 | 180.25M |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 459 | ANGO | AngioDynamics, Inc. | 497.27M | -0.08% | 275,354 | 313.73M |
| 460 | AQST | Aquestive Therapeutics, Inc. | 490.51M | -0.51% | 1,539,363 | 50.27M |
| 461 | EIKN | Eikon Therapeutics, Inc. | 486.16M | 0.22% | 188,926 | - |
| 462 | KIDS | OrthoPediatrics Corp. | 468.24M | -0.49% | 90,261 | 243.30M |
| 463 | KYTX | Kyverna Therapeutics, Inc. | 466.39M | 3.15% | 651,585 | - |
| 464 | CTEV | Claritev Corporation | 461.48M | 4.76% | 90,137 | 978.76M |
| 465 | ARVN | Arvinas, Inc. | 461.33M | -3.64% | 692,610 | 89.40M |
| 466 | NGNE | Neurogene Inc. | 451.93M | 7.97% | 166,595 | 925.00K |
| 467 | FDMT | 4D Molecular Therapeutics, Inc. | 451.67M | - | 565,074 | 88.24M |
| 468 | WEAV | Weave Communications, Inc. | 451.14M | -0.35% | 744,491 | 248.72M |
| 469 | PRTA | Prothena Corporation plc | 448.14M | -2.62% | 313,207 | 57.94M |
| 470 | ASMB | Assembly Biosciences, Inc. | 446.98M | -1.51% | 153,127 | 71.10M |
| 471 | OVID | Ovid Therapeutics Inc. | 440.47M | -1.67% | 1,471,464 | 7.12M |
| 472 | EOLS | Evolus, Inc. | 439.91M | 0.15% | 749,964 | 301.79M |
| 473 | NRC | NRC Health | 435.63M | 0.99% | 118,652 | 138.64M |
| 474 | VREX | Varex Imaging Corporation | 433.69M | 1.98% | 297,049 | 857.50M |
| 475 | CTNM | Contineum Therapeutics, Inc. | 431.06M | 0.35% | 97,538 | - |
| 476 | PACB | Pacific Biosciences of California, Inc. | 428.63M | -4.83% | 4,225,737 | 160.03M |
| 477 | OCGN | Ocugen, Inc. | 426.54M | -1.56% | 3,388,974 | 4.47M |
| 478 | RZLT | Rezolute, Inc. | 426.22M | -4.00% | 2,261,430 | - |
| 479 | KMDA | Kamada Ltd. | 422.76M | 0.98% | 70,405 | 181.68M |
| 480 | STRO | Sutro Biopharma, Inc. | 421.05M | -2.61% | 169,879 | 99.61M |
| 481 | MOBI | Mobia Medical, Inc. | 420.18M | 0.63% | 70,127 | 32.04M |
| 482 | MYGN | Myriad Genetics, Inc. | 414.63M | -3.94% | 843,131 | 829.00M |
| 483 | EBS | Emergent BioSolutions Inc. | 412.77M | -0.87% | 605,394 | 676.80M |
| 484 | ANL | Adlai Nortye Ltd. | 409.20M | 2.81% | 165,567 | 5.00M |
| 485 | CCRN | Cross Country Healthcare, Inc. | 408.69M | - | 285,064 | 1.00B |
| 486 | MNPR | Monopar Therapeutics Inc. | 406.01M | 1.90% | 78,242 | - |
| 487 | EDIT | Editas Medicine, Inc. | 405.91M | -2.40% | 1,477,585 | 38.69M |
| 488 | SGMT | Sagimet Biosciences Inc. | 403.24M | -3.40% | 621,592 | - |
| 489 | CLPT | ClearPoint Neuro, Inc. | 401.26M | 3.80% | 339,574 | 40.61M |
| 490 | VTVT | vTv Therapeutics Inc. | 397.85M | -0.25% | 15,482 | 36.84M |
| 491 | CCCC | C4 Therapeutics, Inc. | 395.55M | -6.75% | 1,951,229 | 34.86M |
| 492 | CGC | Canopy Growth Corporation | 393.11M | -0.97% | 7,866,195 | 203.04M |
| 493 | EPRX | Eupraxia Pharmaceuticals Inc. | 392.90M | 0.67% | 312,184 | - |
| 494 | OFIX | Orthofix Medical Inc. | 391.69M | -5.83% | 384,474 | 825.37M |
| 495 | AUTL | Autolus Therapeutics plc | 388.57M | -4.58% | 1,536,772 | 92.62M |
| 496 | CNXU | Conexeu Sciences Inc. | 385.87M | 0.20% | 90,293 | - |
| 497 | TBRG | TruBridge, Inc. | 385.53M | -0.04% | 283,624 | 345.90M |
| 498 | FBRX | Forte Biosciences, Inc. | 382.91M | -5.15% | 248,923 | - |
| 499 | IPSC | Century Therapeutics, Inc. | 382.35M | -0.47% | 578,917 | 109.16M |
| 500 | PRLD | Prelude Therapeutics Incorporated | 380.84M | 1.31% | 281,278 | 16.72M |